로딩 중…
지수 로딩 중…
Larimar Therapeutics, Inc.
LRMR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$3.64+2.82%
2026-06-18
Price Chart
Larimar Therapeutics, Inc.+32.85%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $378M |
| Revenue | $0.00 |
| Net Income | $-166M |
| Total Assets | $209M |
| Net Assets | $158M |
| Value | |
| P/B | 2.39x |
| FCF Yield | -34.73% |
| Profitability | |
| ROE | -105.04% |
| ROA | -79.61% |
| Financial Health | |
| Debt Ratio | 31.94% |
| Total Debt | $4M |
| FCF | $-131M |
| Cash | $178M |
| Current Ratio | 4.29x |
| Performance | |
| 1Y Return | 32.85% |
| 1M Return | 9.31% |
| From 52W High | -43.30% |
| 1Y MDD | -47.90% |
| Trading | |
| Volume | 2,793,764 shares |
| Trading Value | $10M |
| Per Share | |
| EPS | $-1.94 |
| BPS | $0.92 |